VEGF is also known to enhance osteoclast formation [34, 35] and consistent with this we have found that blockage of VEGF receptor in pre-osteoclasts abolished the ability of human and mouse osteotropic breast cancer cells to enhance osteoclastogenesis and to migrate. This evidence concerns the gene VEGFA and breast carcinoma.